AI in Endoscopy Market Size & Growth Forecast 2027–2036, By Segments (Type of CAD, Component, End Use, Type of Endoscopy), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 22370| Published Date: Oct-2026| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

AI in Endoscopy Market size was assessed at USD 3.25 billion in 2026 and is poised to grow at a 25.81% CAGR between 2027 and 2036, reaching USD 32.29 billion by 2036. The industry revenue for 2027 is estimated at USD 3.99 billion.

Base Year Value (2026)
USD 3.25 billion
CAGR (2027-2036)
25.81%
Forecast Year Value (2036)
USD 32.29 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

AI in Endoscopy Market Intelligence Snapshot

Regional Market Dynamics

  • North America accounted for 46.96% of the market in 2026, driven by advanced healthcare infrastructure, strong AI adoption, medical technology investment, and demand for accurate, consistent endoscopic diagnosis.
  • Asia Pacific is expected to grow fastest as healthcare infrastructure expands, hospitals invest in advanced diagnostics, and rising awareness of early disease detection supports AI-enabled endoscopy adoption.

Segment Momentum

  • Computer-aided detection (CADe) held a 61.8% market share in 2026, reflecting demand for real-time identification of suspicious lesions and polyps. Its integration into endoscopic workflows supports examination consistency and helps clinicians identify abnormalities.
  • Software is the fastest-growing component segment, driven by demand for scalable, upgradeable AI capabilities. Software-based solutions can enhance abnormality detection and lesion characterization while integrating with compatible endoscopic systems without requiring complete equipment replacement.

Market Expansion Drivers

  • AI-assisted polyp detection and real-time diagnostic accuracy improvement.
  • Integration of AI endoscopy solutions with hospital IT and EHR systems.
  • Expansion of AI-driven preventive screening programs and population health initiatives.

Leading Market Participants

  • Major companies in the AI in endoscopy market include Olympus (Japan), Fujifilm (Japan), Medtronic (USA), Stryker (USA), Pentax Medical (Japan), Boston Scientific (USA), Karl Storz (Germany), Siemens Healthineers (Germany), Hologic (USA), Intuitive (USA).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 3.25 billion
  • 2027 Estimated Market Size: USD 3.99 billion
  • Projected Market Size: USD 32.29 billion by 2036
  • Growth Forecast: 25.81% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Type of CAD (CADe) | Component (AI Powered Devices) | End Use (Hospitals) | Type of Endoscopy (Gastrointestinal Endoscopy)
  • Emerging Opportunity Segment: Type of CAD (CADx) | Component (Software) | End Use (Hospitals) | Type of Endoscopy (Gastrointestinal Endoscopy)
Market Dynamics

Market Growth Drivers and Industry Trends

AI-assisted polyp detection and real-time diagnostic accuracy improvement

The increasing integration of artificial intelligence into endoscopic procedures is strengthening diagnostic capabilities through automated polyp detection, lesion characterization, and real-time visual analysis. AI-assisted systems can continuously analyze endoscopic images and highlight suspicious abnormalities that may be difficult to identify consistently through conventional visual inspection alone. This capability is particularly relevant for gastrointestinal screening, where early identification of precancerous lesions can influence subsequent clinical management. Growing clinician interest in decision-support technologies that complement endoscopist expertise is therefore supporting broader adoption of AI-enabled endoscopy platforms.

Integration of AI endoscopy solutions with hospital IT and EHR systems

Integration with hospital information technology infrastructure and electronic health record systems is expanding the practical utility of AI-enabled endoscopy beyond image interpretation. Seamless connectivity allows procedure findings, AI-generated observations, clinical documentation, and relevant patient information to move more efficiently across diagnostic workflows, reducing fragmentation between endoscopy units and broader hospital systems. Increasing emphasis on interoperable healthcare technologies is encouraging providers to favor AI solutions that can operate within established digital environments while supporting documentation, clinical decision-making, quality monitoring, and longitudinal patient management.

Expansion of AI-driven preventive screening programs and population health initiatives

The growing emphasis on preventive healthcare and early disease detection is creating additional opportunities for AI-assisted endoscopy across organized screening programs. Artificial intelligence can support consistent image assessment and help endoscopy teams identify abnormalities during high-volume screening workflows, potentially improving the efficiency and standardization of examinations. As healthcare systems increasingly prioritize population-level cancer prevention and earlier intervention, AI-enabled endoscopy is gaining relevance as a decision-support technology capable of complementing conventional screening protocols and extending advanced diagnostic capabilities across broader patient populations.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
AI-assisted polyp detection and real-time diagnostic accuracy improvement 3.2% Short term (≤ 2 yrs) North America; Europe (Asia Pacific) Medium Fast
Integration of AI endoscopy solutions with hospital IT and EHR systems 2.1% Medium term (2–5 yrs) North America; Asia Pacific (Europe) Medium Moderate
Expansion of AI-driven preventive screening programs and population health initiatives 1.8% Long term (5+ yrs) Asia Pacific; Europe (Latin America) High Moderate

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

AI in Endoscopy Market
Largest Region
North America
46.96% Market Share in 2026

North America (Largest Region)

North America accounted for 46.96% share in 2026, led by the region’s advanced healthcare infrastructure, high adoption of artificial intelligence technologies, and growing use of computer-assisted diagnostic solutions in endoscopic procedures. Healthcare providers are increasingly integrating AI-enabled systems to improve lesion detection, support real-time clinical decision-making, and enhance the consistency of endoscopic examinations. Strong investment in medical technology, increasing awareness of early disease detection, and the availability of sophisticated endoscopy facilities are further supporting regional demand. In addition, the growing focus on improving diagnostic accuracy and reducing variations in clinical interpretation is encouraging the adoption of AI-based endoscopy solutions across hospitals and specialized healthcare centers.

Asia Pacific (Fastest-Growing Region)

The AI in endoscopy market in Asia Pacific is expected to witness the fastest growth, influenced by expanding healthcare infrastructure, rising demand for advanced diagnostic technologies, and increasing awareness of early disease detection. Countries across the region are strengthening healthcare systems and adopting digital technologies to improve diagnostic capabilities, particularly as the burden of gastrointestinal and other endoscopy-detectable conditions increases. Growing investments in hospitals, specialty clinics, and medical technology are creating favorable conditions for AI-enabled endoscopic systems. In addition, the increasing availability of advanced imaging technologies, efforts to improve healthcare accessibility, and growing interest in technology-assisted clinical procedures are contributing to the rapid adoption of AI in endoscopy across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation HubiScaleNascentDeveloping Advanced
Cost-Sensitive RegioniScaleLowMedium High
Regulatory EnvironmentiScaleRestrictiveNeutral Supportive
Demand DriversiScaleWeakModerate Strong
Development StageiScaleEmergingDeveloping Developed
Adoption RateiScaleLowMedium High
New Entrants / StartupsiScaleSparseModerate Dense
Macro IndicatorsiScaleWeakStable Strong
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

AI-Assisted Clinical Workflows

The U.S. market is prioritizing AI tools that enhance endoscopic detection, interpretation, and procedural decision-making. Adoption efforts increasingly focus on integrating AI into clinical workflows, demonstrating practical diagnostic value, and ensuring systems can operate effectively alongside existing endoscopy platforms and healthcare IT environments.

Germany 🇩🇪

Evidence-Based AI Adoption

Germany’s AI in endoscopy market emphasizes clinically credible applications supported by robust validation and integration with established care pathways. Healthcare providers and technology developers are prioritizing reliable lesion detection, workflow compatibility, data protection, and practical implementation within hospital-based endoscopy services.

Japan 🇯🇵

Precision Endoscopy Enhancement

Japan is focusing on AI applications that improve the precision and consistency of endoscopic examination. Market priorities include computer-assisted detection, workflow support, and integration with sophisticated imaging systems, with clinical users seeking technologies that complement specialist expertise and improve examination efficiency.

South Korea 🇰🇷

Imaging Intelligence Integration

South Korea is advancing AI in endoscopy through integration of image-analysis capabilities with increasingly digital clinical workflows. Market priorities include automated detection support, efficient interpretation, and compatibility with advanced imaging infrastructure, enabling healthcare providers to evaluate AI as a practical extension of endoscopic capabilities.

France 🇫🇷

Clinician Workflow Support

France’s AI in endoscopy priorities center on technologies that support clinicians without disrupting established diagnostic workflows. Developers and healthcare institutions are focusing on reliable detection assistance, straightforward system integration, and evidence generation that demonstrates practical benefits for endoscopic examination and decision-making.

Italy 🇮🇹

Diagnostic Efficiency Applications

Italy is exploring AI in endoscopy primarily through applications that can improve diagnostic consistency and support clinicians during examinations. Market priorities include practical workflow integration, dependable image interpretation, and solutions capable of augmenting specialist decision-making without adding unnecessary complexity to existing endoscopy procedures.

AI in Endoscopy Market Share (%), by Type of CAD, 2026

61.8%
CADe
CADx

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Type of CAD Segment Analysis: CADe (Largest Segment) vs CADx (Fastest-Growing Segment)

The computer-aided detection (CADe) segment dominates the type of CAD category with the largest market share of 61.8% in 2026, driven by the growing adoption of artificial intelligence technologies for real-time identification of abnormalities during endoscopic procedures. CADe systems assist clinicians by analyzing endoscopic images and video streams to highlight suspicious lesions, polyps, and other visual abnormalities that may otherwise be difficult to detect through conventional examination. Their ability to provide real-time visual alerts and support consistent examination is particularly valuable in gastrointestinal endoscopy, where early detection of abnormalities can influence diagnostic decisions and subsequent patient management. The increasing emphasis on improving diagnostic accuracy, reducing missed lesions, and standardizing endoscopic examinations is supporting the integration of CADe solutions into clinical workflows. These systems can help reduce the cognitive burden on endoscopists by continuously analyzing visual information and drawing attention to areas that may require further investigation. Advancements in deep learning, computer vision, image processing, and medical video analytics are further enhancing the detection capabilities of AI-powered endoscopy platforms. In addition, growing investments in digital healthcare infrastructure and the increasing adoption of minimally invasive diagnostic procedures are encouraging hospitals and specialized clinics to incorporate CADe technologies. As healthcare providers continue to prioritize early detection, examination quality, and workflow efficiency, CADe is expected to maintain its prominent position in the AI in endoscopy market.

The computer-aided diagnosis (CADx) segment is projected to register the fastest growth in the type of CAD category, supported by the increasing demand for AI-based characterization and clinical decision support during endoscopic procedures. Unlike detection-focused systems, CADx technologies analyze detected abnormalities to provide additional information about their nature, characteristics, and potential clinical significance. These systems can assist clinicians in distinguishing between different tissue types, assessing lesion features, and supporting decisions regarding further investigation, treatment, or removal. The growing emphasis on precision medicine and individualized diagnostic approaches is encouraging the adoption of AI-powered characterization tools that complement conventional endoscopic assessment. Advances in machine learning, deep learning, and high-resolution image analysis are improving the ability of CADx systems to interpret subtle visual patterns and support more consistent clinical evaluations. Their integration with real-time endoscopic imaging platforms can facilitate rapid assessment during procedures and potentially reduce uncertainty in clinical decision-making. In addition, increasing demand for efficient diagnostic workflows, improved lesion characterization, and reduced variability in endoscopic interpretation is supporting interest in CADx solutions. Continued progress in clinical validation, software integration, and usability is expected to strengthen their role in endoscopic practice, accelerating adoption across hospitals and specialized diagnostic centers.

Component Segment Analysis: AI Powered Devices (Largest Segment) vs Software (Fastest-Growing Segment)

The AI-powered devices segment leads the component category with the largest market share of 51.62% in 2026, driven by the increasing integration of artificial intelligence capabilities into endoscopic imaging systems and associated medical equipment. AI-powered endoscopy devices integrate advanced imaging hardware, computational capabilities, and intelligent image analysis functions to support real-time visualization, abnormality detection, and procedural assistance. These devices enable clinicians to obtain enhanced visual information during examinations while incorporating AI-based functions directly into endoscopic workflows. The growing adoption of minimally invasive diagnostic procedures and the need for improved visualization and examination consistency are encouraging healthcare facilities to invest in technologically advanced endoscopic equipment. Integration of AI capabilities into imaging processors, video systems, and endoscopic platforms can facilitate immediate analysis without significantly disrupting existing clinical procedures. Advancements in high-definition imaging, image enhancement, processing efficiency, and intelligent visualization are further improving the functionality of AI-powered devices. In addition, hospitals are increasingly modernizing endoscopy infrastructure to support advanced diagnostic capabilities, improve procedural efficiency, and strengthen patient care. The growing focus on early disease detection, real-time clinical assistance, and technology-enabled healthcare is further supporting demand for AI-integrated devices. As healthcare providers continue to adopt intelligent endoscopic systems, AI-powered devices are expected to remain an important component of the market.

The software segment is projected to register the fastest growth in the component category, driven by continuous advancements in artificial intelligence algorithms, image analysis, and cloud-enabled medical technologies. AI software plays a central role in interpreting endoscopic images, detecting suspicious abnormalities, characterizing lesions, and providing real-time decision support to clinicians. Software-based solutions can be integrated with compatible endoscopic imaging systems, offering opportunities to enhance diagnostic capabilities without requiring complete replacement of existing equipment. The increasing availability of deep learning models and computer vision technologies is improving the ability of AI software to analyze complex visual data and identify patterns that may be challenging to recognize consistently through conventional examination. Growing demand for scalable, upgradeable, and interoperable clinical technologies is also supporting software adoption across healthcare facilities. Software platforms can be updated to incorporate algorithmic improvements, support new diagnostic applications, and adapt to evolving clinical requirements. In addition, the growing emphasis on digital healthcare transformation, workflow automation, and data-driven clinical decision-making is encouraging hospitals to invest in intelligent endoscopy software. Improvements in computing performance, system integration, and user-friendly interfaces are further facilitating implementation in clinical environments. As healthcare providers seek flexible and continuously evolving AI capabilities, software is expected to play an increasingly important role in expanding AI adoption across endoscopic procedures.

End Use Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)

The hospitals segment leads the end use category and is also the fastest-growing segment, driven by the extensive availability of advanced diagnostic infrastructure, specialized clinical personnel, and comprehensive endoscopic services. Hospitals perform a broad range of diagnostic and therapeutic endoscopic procedures for gastrointestinal disorders, cancer screening, and other conditions requiring detailed internal visualization. The integration of artificial intelligence into hospital endoscopy departments supports real-time abnormality detection, improved lesion characterization, and more consistent clinical assessments. Growing emphasis on early diagnosis and minimally invasive procedures is encouraging hospitals to adopt AI-enabled endoscopic technologies to support clinical decision-making and enhance examination workflows. Hospitals also benefit from centralized diagnostic facilities, established medical imaging infrastructure, and multidisciplinary teams that facilitate the implementation of advanced technologies. The rising burden of gastrointestinal diseases and increasing demand for diagnostic procedures are further strengthening the need for efficient and reliable endoscopy solutions. In addition, ongoing investments in healthcare digitalization, intelligent medical equipment, and advanced diagnostic capabilities are supporting the adoption of AI-powered endoscopy systems. Integration with hospital information systems, electronic medical records, and imaging platforms can further improve clinical documentation, workflow coordination, and access to diagnostic information. As hospitals continue to prioritize diagnostic accuracy, operational efficiency, and technology-enabled patient care, they are expected to remain a key end-user group and an important driver of growth in the AI in endoscopy market.

Segment Sub-Segment Largest Segment Fastest Growing
Type of CAD CADx, CADe CADe CADx
Component AI Powered Devices, Software, Services AI Powered Devices Software
End Use Hospitals, Specialty Clinics, Others Hospitals Hospitals
Type of Endoscopy Gastrointestinal Endoscopy, Urological Endoscopy, Respiratory Endoscopy, Colonoscopy, Others Gastrointestinal Endoscopy Gastrointestinal Endoscopy
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

Analyst Perspective:

Adoption of AI-assisted endoscopy hinges on balancing diagnostic precision with real-time operational integration across clinical environments. Systems must maintain low latency and high lesion detection accuracy during live procedures to ensure actionable alerts without triggering alarm fatigue or slowing clinical workflows. Crucially, commercial viability requires seamless hardware interoperability—enabling software compatibility with existing endoscopes and imaging processors across diverse capital budgets. Beyond core algorithm performance, vendors that establish clear regulatory compliance, rigorous data privacy standards, and transparent clinical validation will earn greater trust from healthcare providers managing strict governance mandates.

Key companies in the AI in endoscopy market:

  1. Olympus (Japan)
  2. Fujifilm (Japan)
  3. Medtronic (USA)
  4. Stryker (USA)
  5. Pentax Medical (Japan)
  6. Boston Scientific (USA)
  7. Karl Storz (Germany)
  8. Siemens Healthineers (Germany)
  9. Hologic (USA)
  10. Intuitive (USA)

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Olympus (Japan)
Fujifilm (Japan)
Medtronic (USA)
Stryker (USA)
Pentax Medical (Japan)
Boston Scientific (USA)
Karl Storz (Germany)
Siemens Healthineers (Germany)
Hologic (USA)
Intuitive (USA)
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
INDUSTRY NEWS

Industry Development/News

Company Name Date Key Development
Medi-Globe February 2026 Medi-Globe launched mAI Companion®, a real-time AI assistant for detecting pancreatic lesions during endoscopic ultrasound (EUS). Co-developed with IHU Strasbourg, the solution received MDR CE marking and became available for clinical use in Europe, representing a commercial deployment of AI-assisted lesion detection in pancreatic EUS procedures.
Olympus September 2025 Olympus launched its AI-powered OLYSENSE CAD/AI endoscopy portfolio in the U.S. and Europe, incorporating cloud-based applications including CADDIE, CADU, and SMARTIBD for real-time lesion detection and characterization. The launch expands Olympus's AI-enabled endoscopy capabilities across major markets and strengthens integration of AI tools into clinical endoscopy workflows.
Magentiq May 2024 Magentiq partnered with PENTAX Medical, part of HOYA Group, to integrate its AI-based endoscopy solutions with PENTAX endoscopy systems. The collaboration focuses on incorporating real-time computer-aided detection and diagnostic capabilities into clinical workflows in the U.S., supporting broader commercialization of AI-assisted endoscopy technologies.
Medtronic April 2024 Medtronic unveiled ColonPRO, the next-generation software for its GI Genius intelligent endoscopy system, at the Genius Summit 2024. The software development advances Medtronic’s AI-enabled endoscopy offering and strengthens the capabilities of its existing intelligent endoscopy platform for gastrointestinal diagnostic applications.
Fujifilm March 2024 Fujifilm received 510(k) clearance for its AI-powered CAD EYE technology, designed to enhance colonic polyp detection during endoscopy. The regulatory clearance supports commercialization of AI-assisted detection capabilities and expands the availability of computer-aided diagnostic technology for gastrointestinal endoscopic procedures.
AnX Robotica January 2024 AnX Robotica received FDA clearance for ProScan, an AI-assisted reading tool designed for small bowel video capsule endoscopy. The regulatory authorization advances commercialization of AI-supported interpretation technology for capsule endoscopy and adds automated reading capabilities to the company’s NaviCam platform.
Magentiq Eye July 2023 Magentiq Eye received FDA authorization for its MAGENTIQ-COLO device, an AI-powered solution for colonoscopy that provides clinicians with information on the size, type, and maturity of detected lesions. The authorization represents a significant regulatory milestone for AI-assisted colonoscopy and expands commercially available computer-aided detection capabilities.
AnX Robotica February 2023 AnX Robotica introduced the NaviCam Small Bowel System in the U.S., incorporating improvements intended to reduce download and processing times for video capsule endoscopy studies. The launch expands the company’s NaviCam platform in the U.S. and supports more efficient clinical analysis and diagnosis using small bowel capsule endoscopy.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

AI in Endoscopy Market — Custom Segments

Segment Sub-Segment
AI Deployment Model On-premise, Cloud-based, Hybrid
Workflow Integration Standalone AI, Procedure-integrated AI, EHR-integrated AI, Fully Integrated Clinical Workflow
AI Application Function Lesion Detection, Lesion Characterization, Quality Assessment, Procedural Guidance

AI in Endoscopy Market — Custom TOC

Custom Chapter Chapter Details
AI-Assisted Endoscopy Adoption Pathways
  • Clinical Adoption Drivers and Use-Case Prioritization
  • Specialty and Procedure-Level Adoption Pathways
  • Provider Readiness and Implementation Models
  • Adoption Barriers and Scaling Enablers
  • Emerging AI-Enabled Endoscopy Applications
Hospital AI Procurement & Evaluation
  • Hospital Evaluation Frameworks for AI-Enabled Endoscopy
  • Clinical Evidence and Validation Requirements
  • Technology Assessment and Vendor Due Diligence
  • Integration, Interoperability and Deployment Considerations
  • Procurement Stakeholder Priorities and Decision Pathways
Endoscopy Data Ecosystem Strategy
  • Endoscopy Data Sources and Availability Landscape
  • Data Interoperability and Workflow Infrastructure
  • Annotation, Curation and Data Quality Requirements
  • Data Partnerships and Ecosystem Models
  • Strategic Implications for AI Development and Deployment

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

What is the estimated worth of the AI in endoscopy market?

The market size of AI in endoscopy in 2027 is calculated to be USD 3.99 billion.

How is the AI in endoscopy industry expected to grow over the next 10 years?

AI in Endoscopy Market size was assessed at USD 3.25 billion in 2026 and is poised to grow at a 25.81% CAGR between 2027 and 2036, reaching USD 32.29 billion by 2036.

How is AI-assisted detection changing diagnostic workflows and adoption priorities in endoscopy?

AI-assisted polyp detection, lesion characterization, and real-time image analysis are strengthening interest in technologies that complement endoscopist expertise. These capabilities support more consistent identification of suspicious abnormalities, making diagnostic decision support increasingly relevant to gastrointestinal screening and early disease detection.

Why is integration with hospital IT systems becoming critical for AI endoscopy adoption?

Healthcare providers increasingly value AI solutions that integrate with hospital information systems and electronic health records. Interoperability helps streamline clinical documentation, transfer procedure findings, support decision-making, and improve quality monitoring, making workflow compatibility an important consideration in technology adoption.

Why does computer-aided detection lead the AI in endoscopy market?

Computer-aided detection (CADe) held a 61.8% market share in 2026, reflecting demand for real-time identification of suspicious lesions and polyps. Its integration into endoscopic workflows supports examination consistency and helps clinicians identify abnormalities.

How is AI software creating new opportunities in the endoscopy market?

Software is the fastest-growing component segment, driven by demand for scalable, upgradeable AI capabilities. Software-based solutions can enhance abnormality detection and lesion characterization while integrating with compatible endoscopic systems without requiring complete equipment replacement.

Why does North America lead the AI in endoscopy market?

North America accounted for 46.96% of the market in 2026, driven by advanced healthcare infrastructure, strong AI adoption, medical technology investment, and demand for accurate, consistent endoscopic diagnosis.

How is Asia Pacific creating growth opportunities in the AI in endoscopy market?

Asia Pacific is expected to grow fastest as healthcare infrastructure expands, hospitals invest in advanced diagnostics, and rising awareness of early disease detection supports AI-enabled endoscopy adoption.

What are the key competitors in the AI in endoscopy landscape?

Major companies in the AI in endoscopy market include Olympus (Japan), Fujifilm (Japan), Medtronic (USA), Stryker (USA), Pentax Medical (Japan), Boston Scientific (USA), Karl Storz (Germany), Siemens Healthineers (Germany), Hologic (USA), Intuitive (USA).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →